Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04632329 · ClinicalTrials.gov registry record · NA
Negative Pressure Applied by the Equinox MPD for Severe Open Angle Glaucoma
A NA study of Glaucoma Open-Angle, sponsored by Equinox.
- Completed
- Registry status
- NA
- Development phase
- 64
- Enrollment target
- 3
- Study locations
NCT04632329 is a NA study of Glaucoma Open-Angle that has completed, run by Equinox. The registered enrollment target is 64 participants, below the 162-participant average among 22 other Glaucoma Open-Angle trials with a reported enrollment target (60% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT04632329, a NA study of Glaucoma Open-Angle, has completed, sponsored by Equinox.
- COMPLETED
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
- 3
- Study locations
Study Summary
This is a prospective, non-significant risk, controlled, randomized, multi-center, masked, feasibility study to evaluate the safety and IOP-lowering effectiveness of negative pressure application (via the Mercury MPD) for lowering and titrating intraocular pressure (IOP) in severe open-angle glaucoma (OAG) patients. The study will be conducted at approximately three investigational sites in the United States. Between 60 and 100 subjects will be randomized to treatment. Treatment eyes will be administered two levels of negative pressure, calculated based on 50% and 75% of baseline IOP (as measured by pneumatonometry). One eye of each eligible subject will be randomized to receive negative pressure application with the MPD device; the contralateral eye will be used as a control and will be examined but will not undergo application of negative pressure. Subjects will be treated at each of the negative pressure levels for one hour. All study procedures will be conducted at one visit, and the subject will exit the study at the conclusion of the visit.
Conditions Studied
Interventions
- DEVICE Negative Pressure Treatment via the Mercury Multi-Pressure Dial
Study Locations (3)
Illinois
- Illinois College of Optometry - Chicago
South Dakota
- Vance Thompson Vision - Sioux Falls
Texas
- R and R Eye Research, LLC - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2020-10-28 |
| Est. Completion | 2021-08-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04632329
The ClinicalTrials.gov registry entry for NCT04632329 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 162-participant average among 22 other Glaucoma Open-Angle trials with a reported enrollment target (60% lower). The listed sponsor is Equinox, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Glaucoma Open-Angle appearing as the primary indexed condition, and to 1 intervention - of which Negative Pressure Treatment via the Mercury Multi-Pressure Dial is the first listed.
NCT04632329 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Illinois, South Dakota, Texas.
Frequently Asked Questions
What is clinical trial NCT04632329 about?
NCT04632329 is a clinical study titled "Negative Pressure Applied by the Equinox MPD for Severe Open Angle Glaucoma". This is a prospective, non-significant risk, controlled, randomized, multi-center, masked, feasibility study to evaluate the safety and IOP-lowering effectiveness of negative pressure application (via the Mercury MPD) for lowering and titrating intraocular pressure (IOP) in severe open-angle glaucom...
What is the current status of trial NCT04632329?
This trial is currently completed. It is a NA study. The enrollment target is 64 participants. The study started on 2020-10-28. Estimated completion is 2021-08-19.
What conditions does trial NCT04632329 study?
This clinical trial studies the following conditions: Glaucoma Open-Angle.
What interventions are being tested in trial NCT04632329?
The interventions under investigation include: Negative Pressure Treatment via the Mercury Multi-Pressure Dial (DEVICE).
Who is sponsoring clinical trial NCT04632329?
This trial is sponsored by Equinox, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04632329 being conducted?
This trial has 3 study locations across Illinois, South Dakota, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glaucoma Open-Angle
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Electrical Stimulation for Vision Neuroenhancement in Glaucoma
RECRUITING · NA
-
Electrical Stimulation for the Treatment of Optic Neuropathies
RECRUITING · NA
-
Electrical Stimulation for the Treatment of Glaucoma
RECRUITING · NA
-
Optic Nerve Head Strain as Biomarker for Glaucoma
RECRUITING · NA
-
Results of Patients With Glaucoma Undergoing Minimally Invasive Glaucoma Surgery in Conjunction With Cataract Surgery
RECRUITING · NA
-
A Trial of Hydrus Microstent Versus Goniotomy
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.